XYNVIVO
Live / Applied — Statement of use — processing complete, to examiner (as of 19 Mar 2026)
What this means for you
Not registered yet, but its 08 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98170489
- Mark type
- Stylized text
- Filed
- 08 Sept 2023
- Published for opposition
- 06 Aug 2024
- Attorney of record
- David I. Greenbaum
Goods and services
- Class 010 — Medical apparatus: medical device for producing and delivering cell therapy to a patient, namely, infusion and injection devices for administering drugs
Owner
- Lupagen, Inc., Irving, TX, US
- Lupagen, Inc., Irving, TX, US
Prosecution history
- 19 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Sept 2025 — USE AMENDMENT FILED
- 19 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 12 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Sept 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Sept 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Feb 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 03 Sept 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 06 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2024 — PUBLISHED FOR OPPOSITION
- 17 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Jul 2024 — EXAMINER'S AMENDMENT ENTERED